|
OSBPL9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-15 |
| Normal-vs-Stage2 |
4.14435152862325E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.416000E-01 |
| Stage1-vs-Stage3 |
4.579600E-03 |
| Stage1-vs-Stage4 |
4.953100E-04 |
| Stage2-vs-Stage3 |
1.408600E-01 |
| Stage2-vs-Stage4 |
3.854200E-02 |
| Stage3-vs-Stage4 |
3.402200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.626032641866E-12 |
| Normal-vs-Asian |
2.060400E-03 |
| Caucasian-vs-AfricanAmerican |
5.221200E-01 |
| Caucasian-vs-Asian |
5.856200E-01 |
| AfricanAmerican-vs-Asian |
4.803400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62914126633495E-12 |
| Male-vs-Female |
1.775800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.88800094949693E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.61770002843542E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.405200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.658000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.480400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.703400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.343600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.00269999999225E-05 |
| Normal-vs-Grade 2 |
1.13242748511766E-14 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
8.158500E-03 |
| Grade 1-vs-Grade 3 |
3.631900E-04 |
| Grade 1-vs-Grade 4 |
3.7181000001052E-07 |
| Grade 2-vs-Grade 3 |
5.425800E-04 |
| Grade 2-vs-Grade 4 |
9.64430002525773E-09 |
| Grade 3-vs-Grade 4 |
1.601280E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.98840943710366E-13 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
7.73660002728604E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.14099999448669E-08 |
| N0-vs-N1 |
6.364200E-02 |
|
|
